RareResearch.AI
← Back to atlas

L543R

Category 3/4 — Most DruggablePathogenic/Likely pathogenicTransmembrane · predictedSource card
LeucineArginine at position 543 · TM7 (529-549) · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type L543 — hydrogen bond to M539
Fullscreen ↗
DynaMut2 mutant · L543R
Mutant R543 — polar contact to I547 lost (6 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

6 lost3 gained9 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondM539M539Preserved
Hydrogen bondV546V546Preserved
Hydrogen bondI547I547Preserved
Polar contactM539M539Preserved
Polar contactC541C541Preserved
Polar contactV546V546Preserved
Polar contactI547I547Preserved
Van der WaalsV415Gained
Van der WaalsM539Gained
Van der WaalsC541Gained
Van der WaalsI547I547Preserved
HydrophobicF354Lost
HydrophobicM357Lost
HydrophobicV415Lost
HydrophobicT436Lost
HydrophobicW540Lost
HydrophobicI547Lost
HydrophobicF881F881Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-1.75kcal/mol
Destabilising — moderate
AlphaMissense
0.969
LPath
AlphaFold pLDDT
91
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationPathogenic/Likely pathogenic
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsnot provided; Wolfram-like syndrome; Autosomal dominant nonsyndromic hearing loss 6
Population frequency (gnomAD v4)Ultra-rare · AF 0.000068%
cDNA changec.1628T>G
ClinVar accessionVCV002203523
Last evaluated2024/02/16 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — L543R Variant Card

Molecular Atlas Pilot Variant · RareResearch.AI · Windsor Symposium Demo

Prepared: May 26, 2026 · Schema target: Category 1 or 2 (TBD from DynaMut2)


Identity

FieldValue
VariantL543R
DNA changec.1628T>G
GeneWFS1
ProteinWolframin (890 aa)
UniProt IDO76024
ClinVar accessionVCV002203523
Amino acid changeL → R at position 543

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 54390.94
DomainTM7 (529-549), helical transmembrane
UniProt features at this position
  • Chain: 1-890 Wolframin
  • Transmembrane: 529-549 Helical

Position 543 is in TM7 (residues 529–549), pLDDT 90.94 (very high confidence). Leucine → Arginine inserts a permanent positive charge into the hydrophobic lipid bilayer interior. This is one of the most thermodynamically costly substitutions a transmembrane helix can tolerate — equivalent to dragging a charged ion into a greasy environment.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.9686
am_classLPath
InterpretationLikely pathogenic — strong signal

DynaMut2

FieldValue
Job ID177985958201
ΔΔG (kcal/mol)-1.75 kcal/mol (Destabilising)
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/177985958201

Clinical Evidence

FieldValue
ClinVar classificationPathogenic/Likely pathogenic
Review statuscriteria provided, multiple submitters, no conflicts
Last evaluated2024/02/16 00:00
Associated conditionsnot provided; Wolfram-like syndrome; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Cataract 41; Wolfram syndrome 1

Computational vs Clinical Tension

AlphaMissense 0.969 (LPath). ClinVar Pathogenic/Likely pathogenic, multi-submitter. Strong agreement.


Phenotype focus

Wolfram spectrum + autosomal dominant hearing loss + diabetes + cataract

Carrier story

L543R sits in transmembrane helix 7 — the same helix that anchors R558. Two pathogenic variants, one helix, telling a 'structural neighborhood' story when you rotate the Mol* viewer.

Mechanism hypothesis

Likely severely destabilizing in the TM context. Two possible mechanisms: (1) the protein never inserts properly into the membrane (translocon rejects the malformed helix), or (2) it inserts but the bilayer interfacial penalty distorts neighboring helices — including TM7's connection to R558's loop. Predicting Category 1 or upper Category 2.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • L543R_molstar_viewer.html — interactive 3D viewer (auto-loads and highlights position 543)
  • L543R_variant_card.md — this card
  • L543R_variant_card.html — demo-ready styled version

Final Schema Categorization

Category 2/3 — Most Druggable (chaperone candidate, upper boundary)

L543R produced the largest magnitude of the pilot set (-1.75 kcal/mol) — consistent with inserting a charge into the transmembrane helix interior, but still below the Cat 2 boundary of |ΔΔG| ≥ 2. The fold accommodates the charged residue better than expected, possibly because nearby polar residues in TM7 provide partial compensation. Same druggable category as R558C, but a stronger destabilization signal — likely the higher-yield chaperone screening candidate.


Every assumption documented. Every score sourced. The Atlas standard.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the L543R PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download L543R PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.